Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +49.90%
#3 Velvet Velvet +37.98%
#4 DoubleZero DoubleZero +13.36%
#5 Akedo Akedo +13.09%
#6 HOME HOME +12.74%
#7 Cross Cross +12.16%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.82%
#9 XPIN Network XPIN Network +9.85%
#10 Fake World Assets Fake World Assets +9.79%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.

AQS
Classement en actions #39473
Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company... Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company dedicated to advancing and commercializing therapeutic solutions. Its core operations span critical areas such as neurology, ophthalmology, and transplantation. The company currently markets a range of products, including Vistitan, an ophthalmic treatment designed to alleviate elevated intraocular pressure in individuals suffering from open-angle glaucoma or ocular hypertension. Another key offering is Tacrolimus IR, an immunosuppressant vital for both preventing and treating acute rejection in organ transplant recipients. Aequus also provides its Evolve line of dry eye products, which target various symptoms associated with dry eye disease and blepharitis, such as discomfort, stinging, burning, and dryness, alongside a preservative-free ophthalmic option. In its development pipeline, Aequus is progressing several innovative candidates. These include Topiramate XR and Oxcarbazepine XR, extended-release oral tablets aimed at epilepsy treatment; AQS1303, a transdermal formulation of pyridoxine/doxylamine developed to combat nausea and vomiting during pregnancy; and AQS1304, a cannabinoid-based therapeutic under investigation for neurological disorders. To support its market reach and innovation, Aequus has forged strategic alliances. These include an agreement with Sandoz Canada, Inc. for the promotion of Vistitan; a partnership with Supernus Pharmaceuticals, Inc. for the marketing of its extended-release anti-epileptic drugs; and a collaboration with Medicom Healthcare Ltd. centered on preservative-free ophthalmic treatments. Established in 2013, Aequus Pharmaceuticals Inc. maintains its corporate headquarters in Vancouver, Canada.
Prix de l'action
$0.00359455
Dernière synchronisation: 2025-05-20
Capitalisation boursière
$476.76K
Changement (1 jour)
0.44%
Changement (1 an)
0.00%
Pays
CA
Échange Aequus Pharmaceuticals Inc. (AQS)

Catégorie

Healthcare
Le prix AQS avec la capitalisation boursière de B
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.
AQS
$0.00359455
Capitalisation boursière de Aequus Pharmaceuticals Inc.(AQS)
Capitalisation boursière: $476.76K
En August 2026, Aequus Pharmaceuticals Inc. a une capitalisation boursière de $476.76K. Cela fait de Aequus Pharmaceuticals Inc. la 39473rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Aequus Pharmaceuticals Inc. du 2015 au 2026
AQS par rapport au top 5 des plus populaires stocks
Prix pour AQS L’actif B La capitalisation boursière de B Résultats
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.
$41,237.69 $476.76K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +1,147,228,381.23%
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.
$33,679.57 $476.76K
Apple Inc. Apple Inc.
AAPL
$4.467T +936,962,312.56%
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.
$31,472.87 $476.76K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +875,572,046.23%
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.
$27,896.81 $476.76K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +776,086,334.45%
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.
$21,520.38 $476.76K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +598,694,592.85%